NEW YORK--(BUSINESS WIRE)--Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer Consortium (PCC), a ...
Does a Custom Electronic Health Record Alert System Improve Physician Compliance With National Quality Measures for Palliative Bone Metastasis Radiotherapy? Oncology clinicians are using an increasing ...
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced its participation in the Molecular Analysis for Combination ...
Trial records are sourced from ClinicalTrials.gov and indexed using natural language processing techniques, including named entity recognition, term normalization, and relationship extraction.
NCI-MATCH precision medicine trial makes major contributions to the use of tumor gene testing to select treatment for patients; new data has broad relevance in medicine and provides a roadmap for ...
AI and Invasive Assessment of Coronary Disease (OCT and Beyond) Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results